Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Interferon-alpha × Clear all

Sponsor

Conditions

Melanoma 4 Carcinoma, Renal Cell 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Kidney Neoplasms 3 Pancreatic Neoplasms 2 Multiple Myeloma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia 2 Warts 1 Small Cell Lung Carcinoma 1 Recurrence 1 Papilloma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lung Neoplasms 1 HIV Infections 1 Colorectal Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

fludarabine phosphate 15 Cyclophosphamide 13 Whole-Body Irradiation 12 Peripheral Blood Stem Cell Transplantation 12 Tacrolimus 10 Etoposide 10 Rituximab 8 Mycophenolic Acid 8 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Gemcitabine 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Brentuximab Vedotin 3 Alemtuzumab 3 10-propargyl-10-deazaaminopterin 3 thymoglobulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡